The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of N τ-methylhistidine
Open accessAbstract
The role of glucocorticoids in regulating the rate of muscle protein breakdown was evaluated by measuring excretion of Nτ-methylhistidine during administration of various doses of corticosterone to adrenalectomized rats. Groups of rats received daily subcutaneous injections of 0, 0.2, 0.5, 1.0, 5.0 or 10.0mg of corticosterone/day per 100g body wt. for 7 days, followed by 3 days without hormone treatment, after which they were killed. A group with intact adrenal glands served as an additional control. All animals were pair-fed with the untreated adrenalectomized group. No significant differences were noted in growth rate or Nτ-methylhistidine excretion between the intact or adrenalectomized control groups, or those given 0.2, 0.5 and 1.0mg of corticosterone, whereas growth ceased and Nτ-methylhistidine excretion rose markedly in the groups receiving 5 and 10mg of corticosterone. After these two high doses of corticosterone, but not after lower doses, there was a loss of weight of the gastrocnemius muscle per 100g of final body wt., but not of the soleus and extensor digitorum longus muscles. The two highest doses of corticosterone also resulted in an increase in liver weight per 100g of final body wt. Lower doses of corticosterone did not cause these changes. Plasma corticosterone concentrations, measured on the final day of injection and again at the time of killing, were decreased to near zero by adrenalectomy and were little raised by doses of 0.2 and 0.5mg daily, but were increased to within the normal range by the 1mg dose. At 5 and 10mg doses, plasma corticosterone concentrations were sustained at 2–3 times those of intact rats, and thus in the range reported for rats exposed to severe stress. Rats given 5 and 10mg doses of corticosterone had glycosuria, and showed considerably elevated concentrations of insulin in the plasma. It is concluded that plasma concentrations of glucocorticoids within the normal range do not regulate the rate of muscle protein breakdown, whereas excessive plasma concentrations of corticosteroids, equivalent to those observed in severe stress, can accelerate muscle protein breakdown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1969) · Elsevier eBooks · doi:10.1016/c2013-0-12458-0 · Cited by 1,826
Endogenous Creatinine in Serum and Urine.
Hare, R. S. (1950) · Experimental Biology and Medicine · doi:10.3181/00379727-74-17837 · Cited by 484
The relative importance of muscle protein synthesis and breakdown in the regulation of muscle mass
Millward, D. J., Garlick, P. J., Nnanyelugo, D. O., & Waterlow, J. C. (1976) · Biochemical Journal · doi:10.1042/bj1560185 · Cited by 348
Metabolism of Administered 3-Methylhistidine
Young, V. R., Alexis, S. D., Baliga, B. S., Munro, H. N., & Muecke, W. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45182-x · Cited by 327
Self-citationProtein Turnover in Skeletal Muscle
Goldberg, A. L. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93117-0 · Cited by 320
Loeb, J. N. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609022951007 · Cited by 250
(1964) · Elsevier eBooks · doi:10.1016/c2013-0-12457-9 · Cited by 246
DALLMAN, M. F., & JONES, M. T. (1973) · Endocrinology · doi:10.1210/endo-92-5-1367 · Cited by 245
Relationship between cortisone and muscle work in determining muscle size
Goldberg, A. L., & Goodman, H. M. (1969) · The Journal of Physiology · doi:10.1113/jphysiol.1969.sp008715 · Cited by 175
Haverberg, L. N., Deckelbaum, L. I., Bilmazes, C., Munro, H. N., & Young, V. R. (1975) · Biochemical Journal · doi:10.1042/bj1520503 · Cited by 153
Self-citation
Cited by
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The Molecular Basis of Skeletal Muscle Atrophy
Jackman, R. W., & Kandarian, S. C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00579.2003 · Cited by 1,008
Landys, M. M., Ramenofsky, M., & Wingfield, J. C. (2006) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2006.02.013 · Cited by 853
Glucocorticoid-Induced Skeletal Muscle Atrophy
Schakman, O., Kalista, S., Barbé, C., Loumaye, A., & Thissen, J. P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.036 · Cited by 705
Bird, S. P., Tarpenning, K. M., & Marino, F. E. (2005) · Sports Medicine · doi:10.2165/00007256-200535100-00002 · Cited by 533
Mechanisms of glucocorticoid-induced myopathy
Schakman, O., Gilson, H., & Thissen, J. P. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0606 · Cited by 521
Effects of glucocorticoids on carbohydrate metabolism
Mcmahon, M., Gerich, J., & Rizza, R. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040105 · Cited by 390
May, R. C., Kelly, R. A., & Mitch, W. E. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112344 · Cited by 372
Mechanisms of metabolic dysfunction in cancer-associated cachexia
Petruzzelli, M., & Wagner, E. F. (2016) · Genes & Development · doi:10.1101/gad.276733.115 · Cited by 340
Carnevali, O., de Vivo, L., Sulpizio, R., Gioacchini, G., Olivotto, I., Silvi, S., & Cresci, A. (2006) · Aquaculture · doi:10.1016/j.aquaculture.2006.04.025 · Cited by 314
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Hormonal control of muscle growth
Florini, J. R. (1987) · Muscle & Nerve · doi:10.1002/mus.880100702 · Cited by 313
Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range.
Simmons, P. S., Miles, J. M., Gerich, J. E., & Haymond, M. W. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111227 · Cited by 286
4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle
Shah, O. J., Anthony, J. C., Kimball, S. R., & Jefferson, L. S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e715 · Cited by 286
The National High Blood Pressure Education Program: Thirty Years and Counting
Jones, D. W., & Hall, J. E. (2002) · Hypertension · doi:10.1161/01.hyp.0000018303.61360.28 · Cited by 279
Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases
Hardy, R. S., Raza, K., & Cooper, M. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0371-y · Cited by 265
Romero, L. M., & Remage-Healey, L. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7491 · Cited by 259
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Mechanisms Modulating Skeletal Muscle Phenotype
Blaauw, B., Schiaffino, S., & Reggiani, C. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c130009 · Cited by 256
Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis
Kayali, A. G., Young, V. R., & Goodman, M. N. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.5.e621 · Cited by 136
Self-citationHardy, R. S., Doig, C. L., Hussain, Z., O'Leary, M., Morgan, S. A., Pearson, M. J., Naylor, A., Jones, S. W., Filer, A., Stewart, P. M., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4806 · Cited by 37
Metadata
- Authors
- Tomas, F. M., Munro, H. N., & Young, V. R.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1979-01-15
- Volume
- 178
- Issue
- 1
- Pages
- 139-146
- ISSN
- 0264-6021 (ISSN-L)
- OpenAlex
- W2418044172
- Cited by
- 293
- References
- 18
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.